HC-7366

Clinical trials for HC-7366 explained in plain language.

Never miss a new study

Get alerted when new HC-7366 trials appear

Sign up with your email to follow new studies for HC-7366, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New hope for kidney cancer: drug combo trial launches

Disease control Recruiting now

This early-phase trial tests whether adding a new drug (HC-7366) to standard immunotherapy can help control advanced clear cell kidney cancer. About 35 adults with stage IV disease will receive the combination. The main goal is to check safety and side effects.

Matched conditions: HC-7366

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated May 26, 2026 10:43 UTC

HC-7366

Get alerted when new HC-7366 trials appear

New hope for kidney cancer: drug combo trial launches